Repare Therapeutics earnings were -$84.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RPTX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$28.7M, down 16.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RPTX reported annual earnings of -$84.7M, with -9.7% growth.
Repare Therapeutics Earnings Reports & History FAQ
What were Repare Therapeutics's earnings last quarter?
Repare Therapeutics (NASDAQ: RPTX) reported Q4 2024 earnings per share (EPS) of -$0.68, up 1.49% year over year. Total RPTX earnings for the quarter were -$28.67 million. In the same quarter last year, Repare Therapeutics's earnings per share (EPS) was -$0.67.
Is Repare Therapeutics profitable or losing money?
As of the last Repare Therapeutics earnings report, Repare Therapeutics is currently losing money. Repare Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$84.69 million, a 9.71% decrease year over year.
What was RPTX's earnings growth in the past year?
As of Repare Therapeutics's earnings date in Q2 2025, Repare Therapeutics's earnings has grown year over year. RPTX earnings in the past year totalled -$84.69 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.